WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
DHAI
DIH HOLDING US INC
$64.87M$33.95M$1.21M-$1.00MN/AN/AN/AN/AN/A
DRMA
DERMATA THERAPEUTICS INC
$1.67M$0.00-$8.69M-$8.69M-$27.75N/AN/AN/AN/A
RNXT
RENOVORX INC
$33.53M$0.00-$7.94M-$8.05M-$0.72N/AN/AN/AN/A2024-06-07
ELTX
ELICIO THERAPEUTICS INC
$101.27M$0.00-$36.83M-$38.99M-$8.63N/AN/AN/AN/A
EHAB
ENHABIT INC
$448.89M$1.04B-$19.50M-$83.00M-$1.66-1.72%N/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$8.40B$4.37B-$325.00M-$1.30B-$2.65-1.76%7.35%N/AN/A2024-05-30
GRTX
GALERA THERAPEUTICS INC
$10.12M$0.00-$38.31M-$45.75M-$0.92N/AN/AN/AN/A
BTSG
BRIGHTSPRING HEALTH SERVICES INC
$1.96BN/AN/AN/AN/AN/AN/AN/AN/A
SOLV
SOLVENTUM CORP
$10.71BN/AN/AN/AN/AN/AN/AN/AN/A
ISPC
ISPECIMEN INC
$2.47M$9.27M-$9.41M-$11.57M-$1.28-14.45%N/AN/AN/A2024-05-22
MTEM
MOLECULAR TEMPLATES INC
$9.41M$31.76M-$11.28M-$18.40M-$1.11-33.68%9.90%N/AN/A
BIOL
BIOLASE INC
$5.38M$48.83M-$15.50M-$38.26M-$20.340.13%1.00%N/AN/A
VERO
VENUS CONCEPT INC
$4.00M$73.30M-$26.52M-$37.39M-$6.68-21.70%-9.71%N/AN/A2024-06-05
MNDR
MOBILE-HEALTH NETWORK SOLUTIONS
$65.62MN/AN/AN/AN/AN/AN/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$6.99M$0.00-$4.96M-$7.35M-$0.46N/AN/AN/AN/A
OPGN
OPGEN INC
$3.87M$3.07M-$22.42M-$26.16M-$65.10-7.28%-0.69%N/AN/A2024-06-06
CTNM
CONTINEUM THERAPEUTICS INC
$404.11MN/AN/AN/AN/AN/AN/AN/AN/A
MYMD
MYMD PHARMACEUTICALS INC
$5.49M$0.00-$12.29M-$17.55M-$9.57N/A-100.00%N/AN/A
AXDX
ACCELERATE DIAGNOSTICS INC
$19.34M$12.17M-$46.13M-$59.05M-$4.46-3.47%12.95%N/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$19.04B$16.00B$1.64B-$493.00M-$0.447.22%-1.61%N/AN/A
KA
KINETA INC
$5.89M$5.16M-$16.76M-$17.89M-$1.50186.56%-5.64%N/AN/A2024-06-06
CADL
CANDEL THERAPEUTICS INC
$356.34M$0.00-$33.50M-$37.37M-$1.28N/AN/AN/AN/A
RENB
RENOVARO INC
$143.08M$0.00-$52.90M-$53.93M-$0.78N/AN/AN/AN/A2024-07-19
RANI
RANI THERAPEUTICS HOLDINGS INC
$264.71M$0.00-$25.87M-$33.08M-$1.29N/AN/AN/AN/A2024-05-29
AONC
AMERICAN ONCOLOGY NETWORK INC
$96.71MN/AN/AN/AN/AN/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$5.67M$6.42M-$454.86k-$3.56M-$0.68-24.11%-11.22%N/AN/A
ANVS
ANNOVIS BIO INC
$97.75M$0.00-$47.53M-$47.53M-$5.13N/AN/AN/AN/A2024-06-12
ENGN
ENGENE HOLDINGS INC
$552.18MN/AN/AN/AN/AN/AN/AN/AN/A
EFTR
EFFECTOR THERAPEUTICS INC
$8.80M$0.00-$31.54M-$34.63M-$12.78-100.00%N/AN/AN/A
ZVSA
ZYVERSA THERAPEUTICS INC
$3.51M$0.00-$105.98M-$105.53M-$1.15kN/AN/AN/AN/A
NUWE
NUWELLIS INC
$4.64M$8.90M-$14.21M-$19.93M-$7.375.35%11.44%N/AN/A
PMN
PROMIS NEUROSCIENCES INC
$34.98M$0.00-$11.59M-$11.89M-$0.74N/AN/AN/AN/A
VRPX
VIRPAX PHARMACEUTICALS INC
$905.36k$0.00-$16.89M-$16.89M-$14.42N/AN/AN/AN/A
LIFW
MSP RECOVERY INC
$98.88M$9.71M$274.74M-$70.31M-$6.26-49.50%N/AN/AN/A2024-06-26
TTOO
T2 BIOSYSTEMS INC
$53.29M$7.18M-$38.59M-$45.65M-$11.51-58.15%-6.37%N/AN/A
BPTH
BIO-PATH HOLDINGS INC
$3.59M$0.00-$13.78M-$13.96M-$26.11N/AN/AN/AN/A
COCH
ENVOY MEDICAL INC
$63.50M$297.00k-$22.83M-$23.54M-$0.2138.79%N/AN/AN/A
NRSN
NEUROSENSE THERAPEUTICS LTD
$19.38M$0.00-$8.97M-$11.28M-$0.83N/AN/AN/AN/A2024-05-25
QLGN
QUALIGEN THERAPEUTICS INC
$1.86M$0.00-$11.89M-$13.42M-$2.65N/AN/AN/AN/A2024-07-12
ALZN
ALZAMEND NEURO INC
$4.35M$0.00-$12.35M-$12.40M-$1.87N/AN/AN/AN/A
CNSP
CNS PHARMACEUTICALS INC
$2.56M$0.00-$17.45M-$17.46M-$3.48N/AN/AN/AN/A
CNTG
CENTOGENE NV
$10.51M$52.19M-$20.95M-$38.50M-$1.376.78%3.00%N/AN/A2024-06-28
HCWB
HCW BIOLOGICS INC
$41.98M$1.16M-$26.12M-$27.39M-$0.7643.63%N/AN/AN/A
MOVE
MOVANO INC
$42.65M$852.00k-$27.45M-$27.91M-$0.55N/AN/AN/AN/A
WINT
WINDTREE THERAPEUTICS INC
$2.59M$0.00-$5.32M-$5.96M-$36.34N/A-100.00%N/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$2.08B$2.50B$299.04M-$168.69M-$0.749.82%6.35%N/AN/A
NRXP
NRX PHARMACEUTICALS INC
$43.44M$0.00-$25.28M-$25.65M-$3.14N/AN/AN/AN/A
IVA
INVENTIVA SA
$193.14M$25.18M-$109.06M-$120.03M-$2.6428.59%24.86%N/AN/A2024-05-29
AGEN
AGENUS INC
$224.69M$161.42M-$114.19M-$239.61M-$12.6469.94%7.01%N/AN/A2024-06-11
ARMP
ARMATA PHARMACEUTICALS INC
$89.66M$4.70M-$74.07M-$79.58M-$2.20-7.28%N/AN/AN/A2024-06-12
AKTX
AKARI THERAPEUTICS PLC
$24.09MN/AN/AN/AN/AN/AN/AN/AN/A
CUTR
CUTERA INC
$45.36M$196.64M-$135.39M-$157.56M-$7.91-21.00%3.62%N/AN/A2024-07-12
CERO
CERO THERAPEUTICS HOLDINGS INC
$15.97MN/AN/AN/AN/AN/AN/AN/AN/A
XFOR
X4 PHARMACEUTICALS INC
$151.14M$0.00-$120.35M-$128.91M-$0.69N/AN/AN/AN/A
ALLR
ALLARITY THERAPEUTICS INC
$11.04M$0.00-$11.78M-$20.94M-$410.14N/AN/AN/AN/A
OKYO
OKYO PHARMA LTD
$38.07M$0.00-$13.18M-$13.27M-$0.61N/AN/AN/AN/A
BCTX
BRIACELL THERAPEUTICS CORP
$23.81M$0.00-$17.21M-$12.65M-$0.80N/AN/AN/AN/A2024-06-10
VINC
VINCERX PHARMA INC
$20.14M$0.00-$37.22M-$38.25M-$1.79N/AN/AN/AN/A2024-05-23
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$2.28M$16.73k-$9.75M-$11.30M-$7.00N/AN/AN/AN/A
AMIX
AUTONOMIX MEDICAL INC
$43.41MN/AN/AN/AN/AN/AN/AN/AN/A
CDT
CONDUIT PHARMACEUTICALS INC
$214.84M$0.00-$2.01M-$2.30M-$1.25kN/AN/AN/AN/A
BOLD
BOUNDLESS BIO INC
$236.34MN/AN/AN/AN/AN/AN/AN/AN/A
FBLG
FIBROBIOLOGICS INC
$359.91MN/AN/AN/AN/AN/AN/AN/AN/A
ONMD
ONEMEDNET CORP
$11.21M$1.02M-$22.43M-$23.21M-$0.98-11.37%N/AN/AN/A
ONCO
ONCONETIX INC
$3.55M$758.90k-$44.48M-$45.68M-$2.51N/AN/AN/AN/A
PACS
PACS GROUP INC
$4.22BN/AN/AN/AN/AN/AN/AN/AN/A
ICU
SEASTAR MEDICAL HOLDING CORP
$30.92M$0.00-$32.88M-$33.67M-$1.00N/AN/AN/AN/A
NRXS
NEURAXIS INC
$19.74M$2.30M-$14.15M-$14.57M-$3.73-15.37%N/AN/AN/A
GALT
GALECTIN THERAPEUTICS INC
$196.39M$0.00-$41.25M-$44.78M-$0.74N/AN/AN/AN/A
OTLK
OUTLOOK THERAPEUTICS INC
$186.07M$0.00-$156.86M-$159.13M-$11.41N/A-100.00%N/AN/A
MAIA
MAIA BIOTECHNOLOGY INC
$74.46M$0.00-$23.72M-$23.72M-$1.58N/AN/AN/AN/A
MDAI
SPECTRAL AI INC
$32.17M$19.30M-$19.77M-$20.45M-$1.17-21.53%N/AN/AN/A
ALUR
ALLURION TECHNOLOGIES INC
$81.03M$48.78M-$44.97M-$58.20M-$3.69-25.60%N/AN/AN/A
ERNA
ETERNA THERAPEUTICS INC
$11.25M$115.00k-$19.90M-$22.92M-$4.25N/A-65.16%N/AN/A
NLSP
NLS PHARMACEUTICS LTD
$6.31M$0.00-$12.02M-$12.17M-$0.32N/AN/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$42.99M$0.00-$40.07M-$40.09M-$1.59N/AN/AN/AN/A
BCLI
BRAINSTORM CELL THERAPEUTICS INC
$39.74M$0.00-$14.73M-$15.53M-$0.32N/AN/AN/AN/A
AEON
AEON BIOPHARMA INC
$66.51M$0.00-$323.91M-$323.95M-$8.72N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$42.60M$0.00-$10.84M-$11.46M-$0.07N/AN/AN/AN/A
NKGN
NKGEN BIOTECH INC
$42.56M$0.00-$76.74M-$80.01M-$4.65-100.00%N/AN/AN/A
CLDI
CALIDI BIOTHERAPEUTICS INC
$12.63M$0.00-$27.77M-$29.98M-$0.69N/AN/AN/AN/A2024-05-29
PBM
PSYENCE BIOMEDICAL LTD
$11.72M$0.00$1.52M$1.52M-$0.01N/AN/AN/AN/A
OCEA
OCEAN BIOMEDICAL INC
$55.32M$0.00-$97.33M-$98.59M-$3.91N/AN/AN/AN/A
TVGN
TEVOGEN BIO HOLDINGS INC
$128.40M$0.00-$58.89M-$60.48M-$2.44N/AN/AN/AN/A
NIVF
NEWGENIVF GROUP LTD
$10.93M$0.00-$690.85k-$690.85k-$1.23N/AN/AN/AN/A
NUVO
LAMF GLOBAL VENTURES CORP I
$23.41M$176.00kN/AN/A-$1.86N/AN/AN/AN/A
INKT
MINK THERAPEUTICS INC
$35.07M$0.00-$20.37M-$20.59M-$0.59N/AN/AN/AN/A

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
678+0.74%+2.09%+6.36%-20.75%8.16x6.06x+18.37%+3.70%-27.15%+77.15%Strong Buy
64-0.34%+2.22%+12.40%+8.46%39.05x4.47x-13.16%+6.46%+11.46%+5.34%Buy
18+0.48%+1.89%+7.64%+18.88%32.93x6.42x+33.66%+8.08%+14.20%+10.49%Buy
87+0.27%+0.58%+6.24%-3.67%-1.08x2.21x+12.46%+3.39%+6.12%+31.76%Strong Buy
12-1.10%+0.04%+1.12%+4.69%25.19x3.03x+15.18%+4.74%+11.78%+13.37%Buy
61-0.19%+1.63%-1.19%-22.50%10.68x3.32x+6.76%+2.25%+5.35%+27.15%Buy
51+0.19%+0.62%+4.65%+11.39%37.64x4.62x-92.27%+6.58%+13.67%+14.97%Buy
150-0.33%+1.75%+3.10%-14.72%30.55x3.98x+7.33%+5.24%+8.23%+20.25%Buy
10-0.52%+0.61%+0.95%+26.67%26.75x106.68x-12.18%+3.44%+19.61%+11.48%Buy
56-0.23%+1.99%+6.12%-6.85%59.90x3.63x+11.21%+7.72%+10.03%+18.87%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -41.26% over the past year, underperforming other healthcare stocks by -34 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 34.58% from Cross Country Healthcare's current stock price of $14.49.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best healthcare stock with a Zen Score of 64, which is 40 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -11.18% over the past year, underperforming other healthcare stocks by -4 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 31.01% from Incyte's current stock price of $57.19.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the third best healthcare stock with a Zen Score of 64, which is 40 points higher than the healthcare sector average of 24. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 17.21% over the past year, overperforming other healthcare stocks by 24 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 40.81% from Corcept Therapeutics's current stock price of $28.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)


Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.14%, which is 6 percentage points higher than the healthcare sector average of 2.07%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.95%, which is 6 percentage points higher than the healthcare sector average of 2.07%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.82%, which is 6 percentage points higher than the healthcare sector average of 2.07%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.04% in the last day, and up 1.67% over the last week. Scorpius Holdings was the among the top gainers in the healthcare sector, gaining 55.34% yesterday.

Scorpius shares are trading higher after the company announced expansion in San Antonio with a new storage and testing facility.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.54% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -26.17% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 85 points higher than the healthcare sector average of 15. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -41.26% in the past year. It has underperformed other stocks in the healthcare sector by -34 percentage points.

Are healthcare stocks a good buy now?

50.4% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.73% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.